Influenza A virus with defective M2 ion channel activity as a live vaccine.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Virology

• Publication date

  2002-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/VIRO.2002.1508PMID 12202229
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rescue of influenza A virus from recombinant DNA.

  2007cited by this paper
• Relation of virus particle counts to the hemagglutinating activity of influenza virus suspensions measured by the HA pattern test and by use of the photometric HCU method

  2005cited by this paper
• Immunogenicity and Protective Efficacy of Replication-Incompetent Influenza Virus-Like Particles

  2002cited by this paper
• Influenza A Virus Can Undergo Multiple Cycles of Replication without M2 Ion Channel Activity

  2001cited by this paper
• Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.

  2000cited by this paper
• Genotypic Stability of Cold-Adapted Influenza Virus Vaccine in an Efficacy Clinical Trial

  2000cited by this paper
• Generation of influenza A viruses entirely from cloned cDNAs.

  1999cited by this paper
• The development of live attenuated cold‐adapted influenza virus vaccine for humans

  1999cited by this paper
• The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.

  1998cited by this paper
• Influenza A virus M2 ion channel protein: a structure-function analysis

  1994cited by this paper
• A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease.

  1994cited by this paper
• Molecular and biological changes in the cold-adapted "master strain" A/AA/6/60 (H2N2) influenza virus.

  1993cited by this paper
• Unpacking the incoming influenza virus.

  1992cited by this paper
• The transmembrane domain of influenza A M2 protein forms amantadine-sensitive proton channels in planar lipid bilayers.

  1992cited by this paper
• Influenza virus M2 protein has ion channel activity.

  1992cited by this paper
• Specific structural alteration of the influenza haemagglutinin by amantadine.

  1990cited by this paper
• Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A/Seal/Massachusetts/1/80 (H7N7) influenza virus.

  1982cited by this paper

• A Live Attenuated H1N1 Influenza Vaccine Based on the Mutated M Gene

  2024cites this paper
• Short report Open Access

  2015cites this paper
• Influenza Vaccines: A Moving Interdisciplinary Field

  2014cites this paper
• Using Reverse Genetics to Improve Influenza Vaccines

  2012cites this paper
• The new temperature-sensitive mutation PA-F35S for developing recombinant avian live attenuated H5N1 influenza vaccine

  2012influential citation
• New Strategies for the Development of H5N1 Subtype Influenza Vaccines

  2012cites this paper
• New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges.

  2011cites this paper
• Trends in development of the influenza vaccine with broader cross-protection.

  2010cites this paper
• STUDY TOWARD THE DEVELOPMENT OF ADVANCED INFLUENZA VACCINES

  2009cites this paper
• Novel avian influenza virus vaccines.

  2009cites this paper
• Reverse Genetics of Influenza Viruses – Applications in Research and Vaccine Design

  2008cites this paper
• Can we make vaccines that protect better than natural immunity does?

  2008cites this paper
• Immunological studies of cold-adapted influenza vaccine viruses in mice

  2008cites this paper
• Special Topic: Progress and Challenges in Vaccinology Development of a Vaccine Against Pandemic Influenza Viruses: Current Status and Perspectives

  2008cites this paper
• INFLUENZA B NS 1 TRUNCATION MUTANTS : A LIVE ATTENUATED VACCINE

  2008cites this paper
• Influenza vaccines and vaccination strategies in birds.

  2008cites this paper
• Emerging Infectious Diseases

  2007influential citation
• Confronting Potential Influenza A (H5N1) Pandemic with Better Vaccines

  2007cites this paper
• Biology of Influenza A Virus

  2007cites this paper
• [Influenza A/H5N1 virus outbreaks and prepardness to avert flu pandemic].

  2007cites this paper
• Menace liée au virus influenza A/H5N1 et mise en place de la prévention face à un risque de pandémie de grippe

  2007cites this paper
• Respiratory Viral Vaccines

  2007cites this paper
• Anti-viral approaches against influenza viruses

  2006influential citation
• Pandemic vaccines: promises and pitfalls

  2006cites this paper
• Making Better Influenza Virus

  2006cites this paper
• New concepts of antiviral therapy

  2006cites this paper
• Making Better Influenza Virus Vaccines?

  2006cites this paper
• The role of reverse genetics in the development of vaccines against respiratory viruses

  2005cites this paper
• Avian influenza virus: prospects for prevention and control by vaccination

  2005cites this paper
• Generation of recombinant influenza A virus without M2 ion-channel protein by introduction of a point mutation at the 5' end of the viral intron.

  2005cites this paper
• Influenza vaccines: recent advances in production technologies

  2005cites this paper
• Characterization of P gene-deficient rabies virus: propagation, pathogenicity and antigenicity.

  2005cites this paper
• Generation and characterization of P gene-deficient rabies virus.

  2004cites this paper
• The Ferret: An Animal Model to Study Influenza Virus

  2004cites this paper
• Novel generations of influenza vaccines.

  2003cites this paper
• Rapid CommunicationRescue of Hantaan virus minigenomes

  2003cites this paper
• Activation of Tumor Antigen-Specific Cytotoxic T Lymphocytes (CTLs) by Human Dendritic Cells Infected with an Attenuated Influenza A Virus Expressing a CTL Epitope Derived from the HER-2/neu Proto-Oncogene

  2003cites this paper
• Rescue of Hantaan virus minigenomes.

  2003cites this paper
• Demystifying FluMist, a new intranasal, live influenza vaccine.

  2003cites this paper